Danaher Corporation
A maker of instruments, consumables, and services for biological research and healthcare, Danaher serves labs, hospitals, and drug developers through brands like Beckman Coulter, Cytiva, Pall, and Leica Microsystems. The company was formed in 1984, and the founding brothers named it after Danaher Creek in Montana, where they were fly fishing when they hatched the idea for the business.
4.75% Series A Mandatory Convertible Preferred Stock — Converted to common stock on April 15, 2022
Sold 1.08M
Granted 4.0K · Sold 1.4K
Granted 680
Granted 680
Granted 26.0K · Sold 58.3K
Granted 24.8K · Sold 16.2K
Granted 7.0K
Granted 4.0K · Sold 3.3K
Granted 7.2K
Granted 4.0K
Granted 8.3K
Granted 23.5K · Sold 21.8K
Granted 2.8K
Granted 680
Granted 12.5K
Granted 1.2K
Granted 6.3K · Sold 1.3K
Granted 10.3K · Sold 5.2K
Granted 680
Granted 680
Granted 680
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Rales Mitchell PChairman of Exec. Committee, Director · 11 transactions | -7.5% | 27.56M | — | — | 1.08M |
| Spoon Alan GDirector · 3 transactions | +2.7% | 133.5K | 4.0K | — | 1.4K |
| Zerhouni Elias A.Director · 1 transaction | +4.9% | 50.7K | 680 | — | — |
| Filler LindaDirector · 1 transaction | +1.6% | 46.3K | 680 | — | — |
| Blair RainerPresident & CEO, Director · 6 transactions | -51.3% | 38.0K | 26.0K | — | 58.3K |
| McGrew MatthewExecutive Vice President · 5 transactions | +22.6% | 37.1K | 24.8K | — | 16.2K |
| Sawyer Montgomery Julie AExecutive Vice President · 5 transactions | +31.3% | 22.2K | 7.0K | — | — |
| List TeriDirector · 3 transactions | +3.5% | 21.5K | 4.0K | — | 3.3K |
| Riley Christopher PaulExecutive Vice President · 5 transactions | -12% | 20.4K | 7.2K | — | — |
| Gugino Matthew EEVP & Chief Financial Officer · 2 transactions | — | 19.5K | 4.0K | — | — |
| Gutierrez-Ramos Jose-CarlosSVP, Chief Science Officer · 5 transactions | +56.4% | 19.0K | 8.3K | — | — |
| Ellis Brian WSenior Vice President · 6 transactions | +3% | 15.0K | 23.5K | — | 21.8K |
| Gray R BradleySVP Strategic Development · 2 transactions | +11.1% | 14.5K | 2.8K | — | — |
| Stevens Raymond CDirector · 1 transaction | +11.1% | 13.7K | 680 | — | — |
| Leiken JonathanSVP-Chief Legal Officer · 2 transactions | — | 12.5K | 12.5K | — | — |
| Bouda ChristopherVP, Chief Accounting Officer · 3 transactions | +9.4% | 9.8K | 1.2K | — | — |
| Milosevich Gregory MExecutive Vice President · 7 transactions | +103.5% | 9.1K | 6.3K | — | 1.3K |
| Couchara GeorgeannSVP, Human Resources · 8 transactions | +128.8% | 8.3K | 10.3K | — | 5.2K |
| Sanders A ShaneDirector · 1 transaction | +33.3% | 5.9K | 680 | — | — |
| Dewan FerozDirector · 1 transaction | +39.8% | 4.7K | 680 | — | — |
| Lamanna Charles WDirector · 1 transaction | +100.1% | 1.4K | 680 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -1.18M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.